Tuberculosis Diagnostics Market Size, Share & Trends Report

Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Nucleic Acid Testing, Detection of Latent Infection), By End-use (Diagnostic Laboratories, Hospitals), By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-1-68038-098-9
Number of Report Pages: 150
Format: PDF, Horizon Databook

Historical Range: 2024 - 2030
Forecast Period: 2024 - 2030
Industry: Healthcare

Market Segmentation

Tuberculosis Diagnostics Type Outlook (Volume, Number of Tests; Revenue, USD Million, 2018 - 2030)
- Nucleic Acid Testing
- Detection of Latent Infection (Skin Test & IGRA)
- Detection of Drug Resistance (DST)
- Phage Assay
- Cytokine Detection Assay
- Diagnostic Laboratory Methods
- Radiographic Method
- Other Methods
Tuberculosis Diagnostics End Use Outlook (Volume, Number of Tests; Revenue, USD Million, 2018 - 2030)
- Diagnostic Laboratories
- Hospitals & Clinics
- Others
Tuberculosis Diagnostics Regional Outlook (Volume, Number of Tests; Revenue, USD Million, 2018 - 2030)
- North America
  - North America Tuberculosis Diagnostics Market, by Test Type
    - Nucleic Acid Testing
    - Detection of Latent Infection (Skin Test & IGRA)
    - Detection of Drug Resistance (DST)
    - Phage Assay
    - Cytokine Detection Assay
    - Diagnostic Laboratory Methods
    - Radiographic Method
    - Other Methods
  - North America Tuberculosis Diagnostics Market, by End Use
    - Diagnostic Laboratories
    - Hospitals & Clinics
    - Others
  - U.S.
    - U.S. Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - U.S. Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Canada
    - Canada Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Canada Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Mexico
    - Mexico Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Mexico Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
- Europe
  - Europe Tuberculosis Diagnostics Market, by Test Type
    - Nucleic Acid Testing
    - Detection of Latent Infection (Skin Test & IGRA)
    - Detection of Drug Resistance (DST)
    - Phage Assay
    - Cytokine Detection Assay
    - Diagnostic Laboratory Methods
    - Radiographic Method
    - Other Methods
  - Europe Tuberculosis Diagnostics Market, by End Use
    - Diagnostic Laboratories
    - Hospitals & Clinics
    - Others
  - UK
    - UK Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - UK Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Germany
    - Germany Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Germany Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - France
    - France Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - France Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Italy
    - Italy Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Italy Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Spain
    - Spain Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Spain Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Denmark
    - Denmark Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Denmark Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Sweden
    - Sweden Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Sweden Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Norway
    - Norway Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Norway Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
- Asia Pacific
  - Asia Pacific Tuberculosis Diagnostics Market, by Test Type
    - Nucleic Acid Testing
    - Detection of Latent Infection (Skin Test & IGRA)
    - Detection of Drug Resistance (DST)
    - Phage Assay
    - Cytokine Detection Assay
    - Diagnostic Laboratory Methods
    - Radiographic Method
    - Other Methods
  - Asia Pacific Tuberculosis Diagnostics Market, by End Use
    - Diagnostic Laboratories
    - Hospitals & Clinics
    - Others
  - Japan
    - Japan Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Japan Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - China
    - China Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - China Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - India
    - India Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - India Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - South Korea
    - South Korea Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - South Korea Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Australia
    - Australia Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Australia Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Singapore
    - Singapore Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Singapore Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Thailand
    - Thailand Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Thailand Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
- Latin America
  - Latin America Tuberculosis Diagnostics Market, by Test Type
    - Nucleic Acid Testing
    - Detection of Latent Infection (Skin Test & IGRA)
    - Detection of Drug Resistance (DST)
    - Phage Assay
    - Cytokine Detection Assay
    - Diagnostic Laboratory Methods
    - Radiographic Method
    - Other Methods
  - Latin America Tuberculosis Diagnostics Market, by End Use
    - Diagnostic Laboratories
    - Hospitals & Clinics
    - Others
  - Brazil
    - Brazil Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Brazil Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Argentina
    - Argentina Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Argentina Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
- Middle East & Africa
  - Middle East & Africa Tuberculosis Diagnostics Market, by Test Type
    - Nucleic Acid Testing
    - Detection of Latent Infection (Skin Test & IGRA)
    - Detection of Drug Resistance (DST)
    - Phage Assay
    - Cytokine Detection Assay
    - Diagnostic Laboratory Methods
    - Radiographic Method
    - Other Methods
  - Middle East & Africa Tuberculosis Diagnostics Market, by End Use
    - Diagnostic Laboratories
    - Hospitals & Clinics
    - Others
  - South Africa
    - South Africa Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - South Africa Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Saudi Arabia
    - Saudi Arabia Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Saudi Arabia Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - UAE
    - UAE Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - UAE Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others
  - Kuwait
    - Kuwait Tuberculosis Diagnostics Market, by Test Type
      - Nucleic Acid Testing
      - Detection of Latent Infection (Skin Test & IGRA)
      - Detection of Drug Resistance (DST)
      - Phage Assay
      - Cytokine Detection Assay
      - Diagnostic Laboratory Methods
      - Radiographic Method
      - Other Methods
    - Kuwait Tuberculosis Diagnostics Market, by End Use
      - Diagnostic Laboratories
      - Hospitals & Clinics
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.